Dr. Craig Katz: “Let’s Rethink Self-Help Models for Alcohol”

Gut Microbiome Composition and Food Insecurity Linked to Risk of Cognitive Impairment in Adults

Mount Sinai and Cancer Research Institute Team Up to Improve Patient Outcomes in Immunotherapy

SGLT2 Inhibitor Empagliflozin Treatment Stabilizes Kidney Function in Patients Who Have Had a Heart Attack

Mount Sinai Receives $3.8 Million Grant to Study New Synthetic Drugs and Opioid Overdoses in Emergency Departments to Prevent Deaths

Mount Sinai Dermatologists Use Tape Strips to Map Immune Changes in Common Skin Disease

Being Incarcerated and Living in Areas Where More Have Gone to Jail Is Associated with Higher Death Rates

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Cardiorespiratory Effects of Wildfire Smoke Particles Can Persist for Months, Even After a Fire Has Ended

New Study Shows Most New Cancer Radiation Oncology Specialists Work in Big Cities, Not Small Towns

New Framework for Characterizing Traumatic Brain Injury To Reveal More Detail About Patient’s Condition and Potential for Recovery

Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults